As of August 28, 2026, Biodexa Pharmaceuticals Plc (BDRX) has a DilutionWatch DilutionScore of 67/100, rated HIGH dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Biodexa Pharmaceuticals Plc has a market capitalization of $2.59M, 225.82B shares outstanding, 8 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
📊Float Risk—
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 5%
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (67/100)
Market Data
Market Cap$2.59M
Shares Outstanding225.82B
FloatN/A
Cash$11.48M
Debt$82.1K
Short InterestN/A
Institutional Holdings
8 institutional holders · 63.2K shares
#1
Sabby Management, LLC
38.1K shares
#2
Armistice Capital, LLC
20.0K shares
#3
Gamma Investing LLC
2.8K shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest24.8K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track BDRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BDRX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
Score Coverage Note
- Float Risk is excluded because public-float data is unavailable.
More Research for BDRX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.